Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Klinik für Innere Medizin II - Gastroenterologie und Endokrinologie
Kommissarischer Leiter der Klinik: Prof. Dr. med. Marcin Krawczyk
Sie befinden sich hier: >> Startseite >> Klinische Zentren und Einrichtungen >> Klinische Zentren und Einrichtungen am UKS >> Medizinische Kliniken >> Innere Medizin II >> Forschung >> Publikationen früherer Jahre >> 2014

2014

1.

Altomare DF, Bonfrate L, Krawczyk M, Lammert F, Caputi-Jambrenghi O, Rizzi S, Vacca M, Portincasa P.
The inulin hydrogen breath test predicts the quality of colonic preparation.
Surg Endosc. 2014 May;28(5):1579-87.

2.

Assmann G, Molinger M, Pfreundschuh M, Bohle R, Zimmer V.
Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment.
Springerplus. 2014 Aug 4;3:404.

3.

Beigel F, Teich N, Howaldt S, Lammert F, Maul J, Breiteneicher S, Rust C, Göke B, Brand S, Ochsenkühn T.
Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study.
J Crohns Colitis. 2014 Nov 1;8(11):1471-9.

4.

Boehm J, Eichhorn S, Kornek M, Hauner K, Prinzing A, Grammer J, Lahm H, Wagenpfeil S, Lange R.
Apolipoprotein E genotype, TNF-α 308G/A and risk for cardiac surgery associated-acute kidney injury in Caucasians.
Ren Fail. 2014 Mar;36(2):237-43.

5.

Bouvy-Liivrand M, Heinäniemi M, John E, Schneider JG, Sauter T, Sinkkonen L.
Combinatorial regulation of lipoprotein lipase by microRNAs during mouse adipogenesis.
RNA Biol. 2014 Jan;11(1):76-91.

6.

Casper M, Acalovschi M, Lammert F, Zimmer V.
The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer.
Fam Cancer. 2014 Jun;13(2):243-7.

7.

Casper M, Petek E, Henn W, Niewald M, Schneider G, Zimmer V, Lammert F, Raedle J.
Multidisciplinary treatment of desmoid tumours in Gardner's syndrome due to a large interstitial deletion of chromosome 5q.
QJM. 2014 Jul;107(7):521-7.

8.

Casper M, Acalovschi M, Lammert F, Zimmer V.
The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer.
Fam Cancer. 2014 Jun;13(2):243-7

9.

Dixon PH, Wadsworth CA, Chambers J, Donnelly J, Cooley S, Buckley R, Mannino R, Jarvis S, Syngelaki A, Geenes V, Paul P, Sothinathan M, Kubitz R, Lammert F, Tribe RM, Ch'ng CL, Marschall HU, Glantz A, Khan SA, Nicolaides K, Whittaker J, Geary M, Williamson C.
A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy.
Am J Gastroenterol. 2014 Jan;109(1):76-84.

10.

Erhardt A, Kolligs F, Dollinger M, Schott E, Wege H, Bitzer M, Gog C, Lammert F, Schuchmann M, Walter C, Blondin D, Ohmann C, Häussinger D.
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial.
Cancer Chemother Pharmacol. 2014 Nov;74(5):947-54.

11.

Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA; SIRFLOX Study Group.
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
BMC Cancer. 2014 Dec 1;14:897.

12.

Globisch T, Steiner N, Fülle L, Lukacs-Kornek V, Degrandi D, Dresing P, Alferink J, Lang R, Pfeffer K, Beyer M, Weighardt H, Kurts C, Ulas T, Schultze JL, Förster I.
Cytokine-dependent regulation of dendritic cell differentiation in the splenic microenvironment.
Eur J Immunol. 2014 Feb;44(2):500-10.

13.

Grotemeyer KC, Kaiser R, Grotemeyer KH, Husstedt IW.
Association of elevated plasma viscosity with small vessel occlusion in ischemic cerebral disease.
Thromb Res. 2014 Jan;133(1):96-100.

14.

Hall RA, Liebe R, Hochrath K, Kazakov A, Alberts R, Laufs U, Böhm M, Fischer HP, Williams RW, Schughart K, Weber SN, Lammert F.
Systems genetics of liver fibrosis: identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population.
PLoS One. 2014 Feb 28;9(2):e89279.

15.

Heger E, Lammert F; für die Arbeitsgemeinschaft Geriatrische Gastroenterologie (AGGG) der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS).
[Biliary diseases in the elderly].
Z Gastroenterol. 2014 May;52(5):447-9.

16.

Hochrath K, Stokes CS, Geisel J, Pollheimer MJ, Fickert P, Dooley S, Lammert F.
Vitamin D modulates biliary fibrosis in ABCB4-deficient mice.
Hepatol Int. 2014 Jun 21;8(3):443-452.

17.

Hopp AK, Rupp A, Lukacs-Kornek V.
Self-antigen presentation by dendritic cells in autoimmunity.
Front Immunol. 2014 Feb 13;5:55.

18.

Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R, Albillos A, Lammert F, Wilmer A, Mookerjee R, Vila J, Garcia-Martinez R, Wendon J, Such J, Cordoba J, Sanyal A, Garcia-Tsao G, Arroyo V, Burroughs A, Ginès P.
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.
J Hepatol. 2014 Jun;60(6):1310-24.

19.

Julich H, Willms A, Lukacs-Kornek V, Kornek M.
Extracellular vesicle profiling and their use as potential disease specific biomarker.
Front Immunol. 2014 Sep 1;5:413.

20.

Kempinska-Podhorodecka A, Krawczyk M, Klak M, Blatkiewicz M, Lammert F, Milkiewicz P, Milkiewicz M.
Healthy PNPLA3 risk allele carriers present with unexpected body fat composition. A study of one thousand subjects.
J Gastrointestin Liver Dis. 2014 Mar;23(1):33-7.

21.

Kessler SM, Simon Y, Gemperlein K, Gianmoena K, Cadenas C, Zimmer V, Pokorny J, Barghash A, Helms V, van Rooijen N, Bohle RM, Lammert F, Hengstler JG, Mueller R, Haybaeck J, Kiemer AK.
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
Int J Mol Sci. 2014 Apr 4;15(4):5762-73.

22.

Kolokotronis T, Glanemann M, Wagner M, Bohle RM, Grünhage F.
Giant cell tumor of the distal common bile duct: report of a rare, benign entity that may mimic malignant biliary obstruction.
Int J Colorectal Dis. 2014 Mar;29(3):413-4.

23.

Krawczyk M, Milkiewicz M, Marschall HU, Bartz C, Grünhage F, Wunsch E, Milkiewicz P, Lammert F.
Variant adiponutrin confers genetic protection against cholestatic itch.
Sci Rep. 2014 Oct 9;4:6374.

24.

Leidig-Bruckner G, Grobholz S, Bruckner T, Scheidt-Nave C, Nawroth P, Schneider JG.
Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus.
BMC Endocr Disord. 2014 Apr 11;14:33

25.

Lutz P, Berger C, Langhans B, Grünhage F, Appenrodt B, Nattermann J, Lammert F, Hoerauf A, Sauerbruch T, Strassburg CP, Spengler U, Nischalke HD.
A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis.
Dig Liver Dis. 2014 Nov;46(11):1047-50.

26.

Maan R, van der Meer AJ, Hansen BE, Feld JJ, Wedemeyer H, Dufour JF, Zangneh HF, Lammert F, Manns MP, Zeuzem S, Janssen HL, de Knegt RJ, Veldt BJ.
Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis.
J Hepatol. 2014 Sep;61(3):482-91.

27.

Moehler M, Maderer A, Schimanski C, Kanzler S, Denzer U, Kolligs FT, Ebert MP, Distelrath A, Geissler M, Trojan J, Schütz M, Berie L, Sauvigny C, Lammert F, Lohse A, Dollinger MM, Lindig U, Duerr EM, Lubomierski N, Zimmermann S, Wachtlin D, Kaiser AK, Schadmand-Fischer S, Galle PR, Woerns M; Working Group of Internal Oncology.
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.
Eur J Cancer. 2014 Dec;50(18):3125-35.

28.

Reichert MC, Farmakis G, Bohle RM, Lammert F, Zimmer V.
Cholangiocarcinoma Presenting as Sister Mary Joseph's Nodule: Case Report and Short Review of the Literature.
J Gastrointest Cancer. 2014 Jun;45(2):231-3.

29.

Reichert MC, Raczeck P, Altmeyer K, Zimmer V, Lammert F.
[55-year old man with pain in the lower left abdomen].
Dtsch Med Wochenschr. 2014 Jan;139(3):87-8.

30.

Rusticeanu M, Zimmer V, Schleithoff L, Wonney K, Viera J, Zimmer A, Hübschen U, Bohle RM, Grünhage F, Lammert F.
Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
Clin Genet. 2014 Mar;85(3):300-1

31.

Schiekofer S, Bobak I, Kleber ME, Maerz W, Rudofsky G, Dugi KA, Schneider JG.
Association between a gene variant near ataxia telangiectasia mutated and coronary artery disease in men.
Diab Vasc Dis Res. 2014 Jan;11(1):60-3.

32.

Schneider JG, Farhadfar N, Sivapiragasam A, Geller M, Islam S, Selbs E.
Commercial laboratory testing of excision repair cross-complementation group 1 expression in non-small cell lung cancer.
Oncologist. 2014 May;19(5):459-65.

33.

Steri V, Ellison TS, Gontarczyk AM, Weilbaecher K, Schneider JG, Edwards D, Fruttiger M, Hodivala-Dilke KM, Robinson SD.
Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice.
Circ Res. 2014 Jan 3;114(1):79-91

34.

Stokes CS, Gluud LL, Casper M, Lammert F.
Ursodeoxycholic Acid and Diets Higher in Fat Prevent Gallbladder Stones During Weight Loss: A Meta-analysis of Randomized Controlled Trials.
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1090-1100.e2

35.

Stokes CS, Lammert F.
Reply.
Clin Gastroenterol Hepatol. 2014 Dec 11. pii: S1542-3565(14)01768-6.

36.

Stokes CS, Gluud LL, Casper M, Lammert F.
Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials.
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1090-1100.e2; quiz e61.

37.

Thurner L, Stöger E, Fadle N, Klemm P, Regitz E, Kemele M, Bette B, Held G, Dauer M, Lammert F, Preuss KD, Zimmer V, Pfreundschuh M.
Proinflammatory Progranulin Antibodies in Inflammatory Bowel Diseases.
Dig Dis Sci. 2014 Mar 4.

38.

van der Meer AJ, Hansen BE, Fattovich G, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Duarte-Rojo A, Manns MP, Ieluzzi D, Zeuzem S, Hofmann WP, de Knegt RJ, Veldt BJ, Janssen HL.
Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.
Gut. 2014 May 9.

39.

van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Duarte-Rojo A, Manns MP, Zeuzem S, Hofmann WP, de Knegt RJ, Hansen BE, Janssen HL.
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection.
J Viral Hepat. 2014 Aug;21(8):568-77.

40.

Wiegand J, Wedemeyer H, Franke A, Rößler S, Zeuzem S, Teuber G, Wächtler M, Römmele U, Ruf B, Spengler U, Trautwein C, Bock CT, Fiedler GM, Thiery J, Manns MP, Brosteanu O, Tillmann HL; German Hep-Net Acute Hepatitis B (GAHB) Study Group.
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trial.
J Viral Hepat. 2014 Oct;21(10):744-50.

41.

Zimmer V, Casper M, Lammert F.
Extensive dabigatran-induced exfoliative esophagitis harboring squamous cell carcinoma.
Endoscopy. 2014;46 Suppl 1 UCTN:E273-4.

42.

Zimmer V, Bittenbring J, Fries P, Lammert F.
Severe mixed-type iron overload in alcoholic cirrhosis related to advanced spur cell anemia.
Ann Hepatol. 2014 May-Jun;13(3):396-8.

43.

Zimmer V, Hirano M, Zimmer A, Lammert F.
Diagnosis of mitochondrial neurogastrointestinal encephalomyopathy: Proposal of a clinical algorithm.
Dig Liver Dis. 2014 Apr 9

44.

Zimmer V, Lammert F.
Role of genetics in diagnosis and therapy of acquired liver disease.
Mol Aspects Med. 2014 Jun;37C:15-34.

45.

Zimmer V, Lammert F.
Retrograde transpyloric hemostatic powder intervention of a concealed prepyloric antral ulcer.
Gastrointest Endosc. 2014 Dec;80(6):1207.

46.

Zimmer V, Casper M, Lammert F.
Extensive dabigatran-induced exfoliative esophagitis harboring squamous cell carcinoma.
Endoscopy. 2014;46 Suppl 1 UCTN:E273-4.